Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Editas Medicine, Inc. is a genome-editing company developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology that includes CRISPR/Cas9, CRISPR/Cas12a, engineered forms and foundational intellectual property for both CRISPR systems. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide RNA molecule designed to recognize a particular DNA sequence. It is engaged in discovering, developing, manufacturing, and commercializing durable, precision in vivo gene-editing medicines for a broad class of diseases. Vivo medicines include vivo editing of hematopoietic stem cells (HSCs), liver cells and other tissues. Vivo gene editing in HSCs supports the advancement of research programs to treat non-malignant hematological diseases.
Find out what a historical investment in Editas Medicine Inc. would be worth today using our EDIT stock calculator.
Buying EDIT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Editas Medicine Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in EDIT
What is the ticker symbol of Editas Medicine Inc.?
The ticker symbol for Editas Medicine Inc. is EDIT.
How much is one share of EDIT?
One share of EDIT is valued at $1.64 as of 22 November 2026.
What is the market capitalisation of Editas Medicine Inc. EDIT?
As of 22 November 2026 Editas Medicine Inc. has a market cap of $253.12M.
What is the 52-week high for Editas Medicine Inc. stock?
The Editas Medicine Inc. 52-week high stock price is $3.94.
What is the 52-week low for Editas Medicine Inc. stock?
The Editas Medicine Inc. 52-week low stock price is $1.63.
Can I buy EDIT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy EDIT shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EDIT on Stake
Buy EDIT from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of EDIT from only US$10 with fractional shares